Is incretin-based therapy ready for the care of hospitalized patients with type 2 diabetes? the time has come for GLP-1 receptor agonists!

Stanley Schwartz, Ralph A. Defronzo

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'Is incretin-based therapy ready for the care of hospitalized patients with type 2 diabetes? the time has come for GLP-1 receptor agonists!'. Together they form a unique fingerprint.